Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population

Long-term immunoreactivity to mycobacterial antigens in Bovis Calmette-Guérin (BCG)-vaccinated population is not well investigated. Herein, 361 volunteer healthy donors (HDs) with neonatal BCG vaccination from Shanghai region (China) were enrolled. They were subdivided into ESAT-6/CFP10 (E6C10 ) and...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2021-01, Vol.11, p.608220-608220
Main Authors: Yang, Qing-Yuan, Zhang, Yu-Tong, Xiao, Jia-Ni, Liang, Yu-Shuo, Ji, Ping, Wang, Shu-Jun, Wang, Ying, Chen, Yingying
Format: Article
Language:English
Subjects:
aging
BCG vaccination
healthy population
Immunology
immunoreactive profiles
mycobacterial proteins
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Long-term immunoreactivity to mycobacterial antigens in Bovis Calmette-Guérin (BCG)-vaccinated population is not well investigated. Herein, 361 volunteer healthy donors (HDs) with neonatal BCG vaccination from Shanghai region (China) were enrolled. They were subdivided into ESAT-6/CFP10 (E6C10 ) and ESAT-6/CFP10 (E6C10 ) groups based on gamma-interferon release assays (IGRAs). Three mycobacterial antigens, including Rv0934, Rv3006, and Rv3841, were subjected to the determination of immunoreactivity by ELISPOT assay. The immunoreactivities to three mycobacterial antigens were firstly compared among TB patients (N=39), E6C10 HDs (N=78, 21.61% of HDs) and E6C10 HDs (N=283, 78.39% of HDs). It was revealed that Rv3006 was dominant upon infection, while Rv3841 was likely to be more responsive upon latent TB infection. In E6C10 population, the immunoreactivity to Rv3841 maintained along with aging, whereas those to Rv3006 and Rv0934 attenuated in E6C10 HDs older than 45 years old. Our study implies the shift of dominant antigens at different infection statuses, providing the clues for the selection of mycobacterial antigens in vaccine development and precision revaccination in the future.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.608220